| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
| 02/02/2005 | EP1501819A1 Estrogen receptor modulators |
| 02/02/2005 | EP1501814A1 Semicarbazide derivatives for combating thromboembolic diseases |
| 02/02/2005 | EP1501813A2 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 02/02/2005 | EP1501808A1 Tachykinin receptor antagonists |
| 02/02/2005 | EP1501801A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/02/2005 | EP1501800A1 Bombesin antagonists |
| 02/02/2005 | EP1501798A2 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS |
| 02/02/2005 | EP1501794A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors |
| 02/02/2005 | EP1501791A1 Amino acid analogues |
| 02/02/2005 | EP1501787A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 02/02/2005 | EP1501605A1 Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency |
| 02/02/2005 | EP1501531A1 Method for treating anxiety and mood disorders in older subjects |
| 02/02/2005 | EP1501525A1 Method for producing preparations rich in tocotrienol |
| 02/02/2005 | EP1501524A2 Internal image antibodies for optical imaging and therapy |
| 02/02/2005 | EP1501515A1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501514A2 Protein kinase modulators and methods of use |
| 02/02/2005 | EP1501512A2 4-azasteroid derivatives as androgen receptor modulators |
| 02/02/2005 | EP1501511A1 Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway |
| 02/02/2005 | EP1501508A1 Inhibitors of histone deacetylase |
| 02/02/2005 | EP1501504A1 1-substituted imidazole derivatives as nos inhibitors |
| 02/02/2005 | EP1501503A1 Substantially pure solid form of the enol tautomer of 3-indolypyruvic acid for use in the treatment of central nervous system disturbances |
| 02/02/2005 | EP1501502A2 Carvedilol pharmasolve solvate |
| 02/02/2005 | EP1501500A2 Carvedilol formulations |
| 02/02/2005 | EP1501497A2 Catechin multimers as therapeutic drug delivery agents |
| 02/02/2005 | EP1501493A1 Use of epa and dha in secondary prevention |
| 02/02/2005 | EP1501482A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 02/02/2005 | EP1501467A2 Heterocyclo inhibitors of potassium channel function |
| 02/02/2005 | EP1440161A4 7118, a human arginine n-methyltransferase family member and uses therefor |
| 02/02/2005 | EP1436382A4 9136, a human aldehyde dehydrogenase family member and uses therefor |
| 02/02/2005 | EP1390365B1 Novel sulfonate substituted pyrazol pyridine dervivatives |
| 02/02/2005 | EP1379257A4 Prodrugs of anticancer agents employing substituted aromatic acids |
| 02/02/2005 | EP1362050B1 Pyrimidine derivatives for inhibition of cell-proliferation |
| 02/02/2005 | EP1351980A4 Peptides for activation and inhibition of delta pkc |
| 02/02/2005 | EP1330233B1 Method of treating stroke |
| 02/02/2005 | EP1318820B1 Medicament containing sub-anesthetic concentrations of xenon for use in the treatment of cardiovascular diseases |
| 02/02/2005 | EP1303521B1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 02/02/2005 | EP1303506B1 6-heteroarylphenanthridines |
| 02/02/2005 | EP1285269B1 Lipid uptake assays |
| 02/02/2005 | EP1235574B1 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 02/02/2005 | EP1221490B1 Recombinant adenoviral vectors and their utilization in the treatment of liver cirrhosis |
| 02/02/2005 | EP1165534B1 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments |
| 02/02/2005 | EP1161235B1 Combinations for the treatment of diseases involving angiogenesis |
| 02/02/2005 | CN1575302A Human tissue factor antibodies |
| 02/02/2005 | CN1575291A Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 02/02/2005 | CN1575290A Pyrimidine derivatives and pharmaceutical compositions containing that compounds |
| 02/02/2005 | CN1575289A 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same |
| 02/02/2005 | CN1575283A Piperazine derivatives with CCRI receptor antagonist activity |
| 02/02/2005 | CN1575279A Substituted thioacetamides |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575191A Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors |
| 02/02/2005 | CN1575182A Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/02/2005 | CN1575181A Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 02/02/2005 | CN1575179A Combination product comprising melagatran and dexamethasone |
| 02/02/2005 | CN1575177A Cxcr3 antagonists |
| 02/02/2005 | CN1575176A Process for making substituted pyrazoles |
| 02/02/2005 | CN1575174A Pharmaceutically active isoindoline derivatives |
| 02/02/2005 | CN1575172A Substituted ideno[1, 2-c]isoquinoline derivatives and methods of use thereof |
| 02/02/2005 | CN1575169A Mch antagonists for the treatment of obesity |
| 02/02/2005 | CN1575162A Combination dosage form containing a cholesterol -lowering agent , an inhibitor of the renin-angiotensin, and aspirin |
| 02/02/2005 | CN1572882A Benzamidine derivatives |
| 02/02/2005 | CN1572792A Pyrazolo [4, 3-d] pyrimidine derivatives |
| 02/02/2005 | CN1572318A Composition containing dipeptide of histidine and alanine for reducing uric acid |
| 02/02/2005 | CN1572314A Chinese patent medicine for treating apoplexy and its preparation method |
| 02/02/2005 | CN1572312A Chinese patent medicine for treating cardiac function failure and its preparation method |
| 02/02/2005 | CN1572311A Prepared licorice granule and its preparation method |
| 02/02/2005 | CN1572310A Chuanxiong rhizome volatile oil soft capsule and its preparation method |
| 02/02/2005 | CN1572296A Freeze dried vinpocetine powder injection and its preparation process |
| 02/02/2005 | CN1187370C Connective tissue growth factor fragments and methods and uses thereof |
| 02/02/2005 | CN1187368C Carboxylic derivs. of diosgenin and process for preparing same |
| 02/02/2005 | CN1187364C 类固醇衍生物 Steroid derivatives |
| 02/02/2005 | CN1187361C Phosphoric-acid substituted benzo-aza-tropone-N-acetic acid derivative, preparing method and medicine thereof |
| 02/02/2005 | CN1187358C Tetrahydro-heterocyclozaepinyl pyrimidine derivatives |
| 02/02/2005 | CN1187354C Adenosine receptor antagonists and methods of making and using the same |
| 02/02/2005 | CN1187351C Bispidine compounds, their use and preparation method, intermediate and pharmaceutical compositions containing same |
| 02/02/2005 | CN1187350C Bispidine compounds, their use and preparation method, intermediate and pharmaceutical compositions containing same |
| 02/02/2005 | CN1187338C 5-phenyl-pyrimidine derivatives |
| 02/02/2005 | CN1187337C Thiobenzimidazole derivatives |
| 02/02/2005 | CN1187336C New imidazole derivatives |
| 02/02/2005 | CN1187332C Tetrahydroisoquinoline hydroximic acid sulfamide compound, its synthesis method and its application |
| 02/02/2005 | CN1187330C Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/02/2005 | CN1187326C Novel compounds |
| 02/02/2005 | CN1187325C Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 02/02/2005 | CN1187318C Solid composition suitable for oral administration comprising non hydroscopic salts of L-carnitine or alkanoyl-L-carnitine with 2-aminoethanesulfonic acid |
| 02/02/2005 | CN1187087C Application of Batroxobin in preparing medicine for preventing and treating deficient blood-reperfusion disturbance |
| 02/02/2005 | CN1187085C Application of erythropoietin in producing medicine for treating cerebral ischemia |
| 02/02/2005 | CN1187075C Preparation method of fresh gastrodia whole powder |
| 02/02/2005 | CN1187070C Suppository for treating piles and other anorectal diseases and its preparation method |
| 02/02/2005 | CN1187066C Antiatherosclerotic |
| 02/02/2005 | CN1187060C Extracts of shark cartilage, its preparation method and usage |
| 02/02/2005 | CN1187056C Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method thereof, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 02/02/2005 | CN1187055C Dioscin element medicine for treating myocardial ischemia, angina pectoris and cardiac infarction |
| 02/02/2005 | CN1187054C Osmosis pump controlled release preparation containing Chinese medicine of cyclovirobuxine D, and preparing method thereof |
| 02/02/2005 | CN1187051C Xanthine-based compound for preparation of medicine for enhancing insulin action |
| 02/02/2005 | CN1187050C Endothelin antogonist and a renin-angiotensin system inhibitor as a combined preparation |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849718 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 02/01/2005 | US6849663 Particularly septic shock |
| 02/01/2005 | US6849658 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |